David Halbert is the founder of Caris Life Sciences. Caris Life Sciences has raised $1.3B in total funding. Latest round: IPO. Backed by Sixth Street.
David Dean Halbert is the founder of Caris Life Sciences, having acquired the early-stage company Molecular Profiling Institute in 2008 to develop a blood-based platform for early disease detection. Following significant expansion and a name change to Caris Life Sciences, the company went public on Nasdaq in 2025, securing approximately $494 million. Halbert is recognized as a new biotech billionaire resulting from the company's IPO.
Full founder directory · Investor directory · Company funding database · Fundraising library